Mechanisms Regulating Human NK Cell Cytotoxicity

人类 NK 细胞细胞毒性的调节机制

基本信息

  • 批准号:
    9919370
  • 负责人:
  • 金额:
    $ 39.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-05-17 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

NK cells are a subpopulation of lymphocytes whose unique receptors facilitate the detection of infected, transformed, or `stressed' cells. This immune recognition subsequently leads to the development of NK cell- mediated cytotoxicity or the generation of cytokines and chemokines that activate other components of the immune system. Patients with hyper-IgE syndrome (HIES) have immune dysregulation and can be affected by recalcitrant cutaneous herpes virus and papillomavirus infections. A major genetic abnormality found in these patients is deletion or loss-of-function mutations in the gene encoding Dedicator of Cytokinesis 8 (DOCK8), a guanine nucleotide exchange factor (GEF) for Cdc42. The high incidence of recurrent cutaneous viral infections in DOCK8-deficient patients is suggestive of defects in natural killer (NK) cell function. In fact, others and we have recently shown that NK cells deficient in DOCK8 have reduced lytic function, decreased adhesion, F-actin accumulation at the cytotoxic synapse and an inability to polarize lytic granules toward the target cell. However, how DOCK8 can regulate so many critical steps in the development of NK cell killing is not known. It is our central hypothesis that the DOCK8-interactome coordinates the regulation of the actin and microtubule cytoskeletons to facilitate NK cell polarization and effect NK cellular cytotoxicity. Based on the preliminary data included in this proposal, we hypothesize that: (a) DOCK8 activation of CDC42 is critical to the development of NK cell killing; (b) DOCK8 interaction with WASP is critical for its localization and F-actin generation at the NKIS; (c) talin recruitment by DOCK8 mediates NK cell – target adhesion; (d) HkRP3, a hematopoietically expressed protein that interacts with DOCK8 is involved in MTOC polarization and lytic granule clustering and affects lytic granule clustering through its interactions with tubulin and the dynein motor complex; (e) septins are DOCK8 interacting proteins that regulate NK cell killing; (f) BORG stabilization of septin filaments is impaired by active Cdc42 in order to regulate NK cell killing. In order to test these hypotheses we will: (1) Determine the mechanism by which DOCK8 regulates F-actin dynamics and cell adhesion; (2) Define the mechanism by which HkRP3 regulates lytic granule convergence and MTOC polarization; (3) Determine the role of septins in the regulation of the NK cell cytotoxicity. The outcome of the proposed experiments will provide an experimental basis for understanding the molecular events that are involved in the regulation of NK cell effector functions, and will, in a broader context, advance our understanding of fundamental processes in cellular activation leading to F-actin regulation, MTOC polarization and granule exocytosis. Moreover, the information obtained through these studies will likely instruct how DOCK8 is functioning in other immune cells.
NK细胞是淋巴细胞的亚群,其独特的受体有助于检测感染, 转化的或“应激的”细胞。这种免疫识别随后导致NK细胞的发育- 介导的细胞毒性或细胞因子和趋化因子的产生,所述细胞因子和趋化因子激活细胞的其它组分。 免疫系统高IgE综合征(HIES)患者存在免疫失调, 皮肤疱疹病毒和乳头瘤病毒感染。一个主要的遗传异常发现在这些 患者是编码胞质分裂贡献因子8(DOCK 8)的基因中的缺失或功能丧失突变, 鸟嘌呤核苷酸交换因子(GEF)用于Cdc 42。复发性皮肤病毒感染的高发病率 DOCK 8缺陷患者中的感染提示自然杀伤(NK)细胞功能缺陷。其实别人 我们最近发现,DOCK 8缺陷的NK细胞具有降低的溶解功能, 粘附,F-肌动蛋白在细胞毒性突触处积聚,并且不能将颗粒溶解在细胞内。 靶细胞。然而,DOCK 8如何调节NK细胞杀伤发展中的如此多的关键步骤, 不知道。我们的中心假设是DOCK 8相互作用组协调肌动蛋白的调节, 和微管细胞骨架以促进NK细胞极化并影响NK细胞的细胞毒性。 基于本提案中包括的初步数据,我们假设:(a)DOCK 8激活CDC 42 (B)DOCK 8与WASP的相互作用对其定位是关键的 和NKIS处F-肌动蛋白的产生;(c)DOCK 8募集塔林介导NK细胞-靶向粘附;(d) HkRP 3是一种与DOCK 8相互作用的造血表达蛋白,参与MTOC极化, 溶解颗粒聚集,并通过与微管蛋白和动力蛋白的相互作用影响溶解颗粒聚集 马达复合物;(e)septins是调节NK细胞杀伤的DOCK 8相互作用蛋白;(f)博格稳定 Septin丝的活性受到活性Cdc 42的损害,以调节NK细胞的杀伤。为了测试这些 假设我们将:(1)确定DOCK 8调节F-肌动蛋白动力学和细胞增殖的机制。 (2)明确HkRP 3调节溶解颗粒会聚和MTOC的机制 (3)确定septins在NK细胞杀伤活性调节中的作用。的结果 提出的实验将为理解分子事件提供实验基础, 参与调节NK细胞效应功能,并将在更广泛的背景下,推进我们的研究。 理解细胞活化的基本过程,导致F-肌动蛋白调节,MTOC极化 和颗粒胞吐作用。此外,通过这些研究获得的信息可能会指导如何 DOCK 8在其他免疫细胞中发挥作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.
参与 NK 细胞溶细胞功能的质膜近端细胞步骤的分子调节。
  • DOI:
    10.1242/jcs.240424
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Phatarpekar,PrasadV;Billadeau,DanielD
  • 通讯作者:
    Billadeau,DanielD
Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release.
  • DOI:
    10.3389/fimmu.2022.871106
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL D BILLADEAU其他文献

DANIEL D BILLADEAU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL D BILLADEAU', 18)}}的其他基金

Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
NSCLC中移植肽抑制EGFR蛋白-蛋白相互作用的分子机制
  • 批准号:
    10850407
  • 财政年份:
    2021
  • 资助金额:
    $ 39.75万
  • 项目类别:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
NSCLC中移植肽抑制EGFR蛋白-蛋白相互作用的分子机制
  • 批准号:
    10593963
  • 财政年份:
    2021
  • 资助金额:
    $ 39.75万
  • 项目类别:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
NSCLC中移植肽抑制EGFR蛋白-蛋白相互作用的分子机制
  • 批准号:
    10095909
  • 财政年份:
    2021
  • 资助金额:
    $ 39.75万
  • 项目类别:
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
NSCLC中移植肽抑制EGFR蛋白-蛋白相互作用的分子机制
  • 批准号:
    10378472
  • 财政年份:
    2021
  • 资助金额:
    $ 39.75万
  • 项目类别:
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research
NIDDK 发现和转化研究多学科博士前培训
  • 批准号:
    10392357
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational Research
NIDDK 发现和转化研究多学科博士前培训
  • 批准号:
    10612790
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
Mechanisms Regulating Human NK Cell Cytotoxicity
人类 NK 细胞细胞毒性的调节机制
  • 批准号:
    9274925
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of Nutrient Homeostasis by COMMD proteins
COMMD 蛋白对营养稳态的调节
  • 批准号:
    10579910
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of Nutrient Homeostasis by COMMD proteins
COMMD 蛋白对营养稳态的调节
  • 批准号:
    10394205
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulation of Copper Homeostasis by COMMD proteins
COMMD 蛋白对铜稳态的调节
  • 批准号:
    9316602
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 39.75万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 39.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了